Table 5 Classification of incident ADEs by organ system, WSUTRH, February 2021 to July 2021
Organ system | Incidence | Adverse drug events | Medications |
|---|---|---|---|
Gastrointestinal | 17 (26.7) | Dyspepsia 3 (4.7) | Diclofenac (2), atorvastatin (1) |
Upper GI bleeding 2 (3.1) | Aspirin (1), diclofenac (1) | ||
Diarrhoea 3 (4.7) | Clarithromycin (1), Omeprazole (2) | ||
Vomiting 5 (7.8) | Digoxin (1) iron sulfate (4) | ||
Loss of appetite 2 (3.1) | Aspirin (1), atorvastatin (1) | ||
Constipation 2 (3.1) | Haloperidone (1) tramadol (1) | ||
Central nervous system | 15 (23.4) | Loss of consciousness 1 (1.6) | Furosemide (1) |
Sedation 2 (3.1) | Diazepam (2) | ||
Dizziness 2 (3.1) | Furosemide (2) | ||
Seizure 3 (4.7) | Insulin (1), tramadol (2) | ||
Hallucination 3 (4.7) | Phenytoin (1), Phenobarbitone (2) | ||
Headache 4 (6.2) | Nifedipine (2), enalapril (2) | ||
Endocrine and metabolic | 7 (10.9) | Hyperkalemia 1 (1.6) | Spironolactone (1) |
Hyperglycemia 1 (1.6) | Dexamethasone (1) | ||
Hypocalcemia 2 (3.1) | phenytoin (1) furosemide (1) | ||
Hypokalemia 2 (3.1) | Digoxin (1), furosemide (1) | ||
Hypoglycemia 1 (1.6) | Insulin (1) | ||
Cardiovascular system | 7 (10.9) | Hypotension 2 (3.1) | Furosemide (2) |
Peripheral oedema 1 (1.6) | Nifedipine (1) | ||
Bradycardia 3 (4.7) | Propranolol (2) digoxin (1) | ||
Shock 1 (1.6) | Propranolol (1) | ||
Neuromuscular and skeletal | 5 (7.8) | Muscle stiffness 3 (4.7) | Chlorpromazine (3) |
myalgia 2 (3.1) | Atorvastatin (2) | ||
Dermatologic | 5 (7.8) | Skin rash 3 (4.7) | amoxicillin/ clavulanate (Augmentin) (1), cotrimoxazole (2) |
Injection site phlebitis 2 (3.1) | Erythromycin (1), vancomycin (1) | ||
Respiratory | 4 (6.2) | Cough 2 (3.1) | Enalapril (2) |
Loss of hearing 1 (1.6) | Gentamycin (1) | ||
respiratory depression 1 (1.6) | Phenobarbitone (1) | ||
Immune system | 2 (3.1) | Allergy 2 (3.1) | Ibuprofen (1), aspirin (1) |
Hematologic | 2 (3.1) | Nose bleeding 1 (1.6) | Enoxaparin (1) |
Anemia 1 (1.6) | Artesunate (1) | ||
Total | 64 (100) | Â | |